Recombinant Zebrafish AP2M1A
Cat.No. : | AP2M1A-11856Z |
Product Overview : | Recombinant Zebrafish AP2M1A full length or partial length protein was expressed. |
- Specification
- Gene Information
- Related Products
- Download
Source : | Mammalian Cells |
Species : | Zebrafish |
Tag : | His |
Form : | Liquid or lyophilized powder |
Endotoxin : | < 1.0 eu per μg of the protein as determined by the LAL method. |
Purity : | >80% |
Notes : | This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications. |
Storage : | Store it at +4 oC for short term. For long term storage, store it at -20 oC~-80 oC. |
Storage Buffer : | PBS buffer |
Gene Name : | ap2m1a adaptor-related protein complex 2, mu 1 subunit, a [ Danio rerio (zebrafish) ] |
Official Symbol : | AP2M1A |
Gene ID : | 321051 |
mRNA Refseq : | NM_212577 |
Protein Refseq : | NP_997742 |
UniProt ID : | Q6NWK2 |
Products Types
◆ Recombinant Protein | ||
AP2M1A-8435Z | Recombinant Zebrafish AP2M1A | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Reviews
- Q&As
Customer Reviews (4)
Write a reviewIt can simplify complex chemical reactions and improve high yield, and its scientific research value is self-evident.
AP2M1A of this recombinant protein is very environmentally friendly.
AP2M1A production process is strictly controlled and the product quality is guaranteed.
The reproducibility of AP2M1A is simply unmatched, and the results are identical in every experiment or application, fully demonstrating its high stability and reliability.
Q&As (18)
Ask a questionThe synthesis of AP2M1A can be achieved by protein engineering, gene recombination and fermentation technology.
The AP2M1A can be used as a biomarker for the diagnosis and treatment of malignant tumors such as breast cancer.
The expression of AP2M1A can be detected by immunohistochemistry, immunofluorescence and enzyme-linked immunosorbent assay.
At present, the clinical application of recombinant AP2M1A is limited by sample size, detection methods and experimental specifications.
The diagnostic accuracy of AP2M1A as a tumor marker depends on the specific detection method used and its clinical application.
Yes, expression of AP2M1A is closely related to cancer prognosis, and patients with high expression levels have a relatively poor prognosis.
Yes, there are polymorphisms in the AP2M1A gene, including single nucleotide polymorphisms and frameshift mutations.
At present, AP2M1A can be used as a potential drug for targeted therapy, and has certain inhibitory effect on breast cancer, gastric cancer and other tumors.
No, the recombinant AP2M1A protein needs to be used in conjunction with other tumor markers to improve the accuracy of cancer diagnosis.
The change of expression of AP2M1A may be related to the therapeutic effect, but further studies are needed to confirm it.
At present, the application of AP2M1A in clinical preventive screening is still in the exploration stage.
Compared with other tumor markers, AP2M1A is expressed earlier in the tumor growth process, and its expression is closely related to the degree of tumor cell invasion and prognosis.
At present, there is no sufficient evidence to support the ability of recombinant AP2M1A to replace conventional chemotherapy and radiotherapy.
The AP2M1A is an artificially manufactured protein constructed from the protein sequence encoded by the human AP2M1A gene.
AP2M1A can be used in the diagnosis of breast cancer, lung cancer, stomach cancer, colon cancer, cervical cancer and other malignant tumors.
The expression of AP2M1A is closely related to the invasion and metastasis of malignant tumors, and may be used as a potential marker for the study of tumor metastasis.
At present, molecular genetics and epigenetics can be used to regulate the expression of AP2M1A gene.
As a tumor marker, AP2M1A has diagnostic and therapeutic potential. With the progress of related technology and research, its prospect in clinical application is worth looking forward to.
Ask a Question for All AP2M1A Products
Required fields are marked with *
My Review for All AP2M1A Products
Required fields are marked with *
Inquiry Basket